Evrysdi® (risdiplam) Pregnancy Registry
Do you have spinal muscular atrophy (SMA) and are you or have you been pregnant? Have you taken Evrysdi® (risdiplam) less than 1 month before getting pregnant or anytime during your pregnancy? If so, you may be able to take part in this registry. Get in touch with the coordinating center to learn more.
Call to learn moreAbout pregnancy and SMA
The effects of a particular treatment on the health of an unborn baby are often unknown because pregnant women are rarely included in clinical research studies evaluating a potential new treatment. Pregnancy registries aim to collect information that could support women and their healthcare providers in making more informed decisions about using a particular treatment during pregnancy and breastfeeding in the future.
What is the Evrysdi Pregnancy Registry?
The Evrysdi Pregnancy Registry is for women with SMA who are or have been pregnant while taking Evrysdi® (risdiplam). This is defined as taking risdiplam less than1 month before getting pregnant or anytime during pregnancy. A pregnancy registry is an observational study that gathers information about participants without providing any additional treatments or medications.
The purpose of this pregnancy registry is to learn more about the health of pregnant women who received risdiplam and the health of their babies. Participants will be asked to share information about their health, their pregnancy and breastfeeding, and their baby’s health during their participation in the registry. Participants will not be required to take any additional or investigational medications other than the medications that they already take as part of their routine care.
The Evrysdi Pregnancy Registry aims to gather information about how pregnancies and babies may or may not be affected for pregnant women who are exposed to risdiplam in the future.
Have questions?
Have questions?
Visit the FAQs section for the answers to common questions that you may have about the Evrysdi Pregnancy Registry.
Am I eligible?
You may be able to take part in this registry if you have SMA and:
and
Call now
Information for patients
Download the Information Booklet for pregnant women who have received Evrysdi® (risdiplam)
How do I participate?
Call the coordinating center at (001) 833-760-1098
Call nowContact the coordinating center by email: hdvchpedsneuromuscul@spectrumhealth.org
For the latest important safety information, please refer to the full Prescribing Information and Patient Information. This is not intended to replace discussions with your healthcare provider.